Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

K18-hACE2 mice develop respiratory disease resembling severe COVID-19

PLoS Pathogens(2021)10.1371/journal.ppat.1009195Source: DataRank Database

K18-hACE2 mice develop respiratory disease resembling severe COVID-19 is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 334 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access334 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 18.40)OA: goldTopics (71)Linked Datasets (14)DataCite Reuse (14)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Julia R. Port ORCID,Trenton Bushmaker ORCID,Irene Owusu Donkor ORCID,Jyothi N. Purushotham ORCID,Victoria A. Avanzato ORCID

Live enrichment

PubMed:33465158 OpenAlex:https://openalex.org/W3123064250

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: 1ZIAAI001179-01

Virus Ecology Unit

NIGMS NIH HHS

Grant: T32 GM008169

Intramural NIH HHS

Grant: ZIA AI001179

Intramural NIH HHS

Grant: 1ZIAAI00117901

FWCI

18.40

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009195&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009195&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009195

journalhttps://doi.org/10.1371/journal.ppat.1009195

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33465158

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-190301 basic medicine03 medical and health sciencesAngiotensin-Converting Enzyme 2AnimalsCOVID-19Disease Models, AnimalFemaleHumansKeratin-18LungLymphocytesMacrophagesMaleMiceMice, TransgenicPromoter Regions, GeneticSARS-CoV-2Trachea

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2AnimalsDisease Models, AnimalFemaleHumansLungLymphocytesMacrophagesMaleMice, TransgenicPromoter Regions, GeneticTracheaMiceKeratin-18

Keywords

Respiratory tractProinflammatory cytokineBiologyImmunologyVirologyViral replicationLungPathogenesisPathologyVirusRespiratory systemInflammationMedicineInternal medicineMaleKeratin-18QH301-705.5SARS-CoV-2MacrophagesCOVID-19Mice, TransgenicRC581-607TracheaDisease Models, AnimalMiceAnimalsHumansFemaleAngiotensin-Converting Enzyme 2LymphocytesImmunologic diseases. AllergyBiology (General)Promoter Regions, GeneticResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants

10.6084/m9.figshare.24715421.v1figshare

Additional file 1 of Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants

10.6084/m9.figshare.24715421figshare

Additional file 1 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728342.v1figshare

Additional file 1 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728342figshare

Additional file 6 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728360figshare

Additional file 6 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728360.v1figshare

Additional file 5 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728357.v1figshare

Additional file 4 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728354.v1figshare

Additional file 5 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728357figshare

Additional file 3 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728348figshare

Additional file 4 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728354figshare

Additional file 2 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728345figshare

Additional file 3 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728348.v1figshare

Additional file 2 of Neuropathological lesions in intravenous BCG-stimulated K18-hACE2 mice challenged with SARS-CoV-2

10.6084/m9.figshare.26728345.v1figshare